A pathological increase in the strength or frequency of neuroendocrine signals that stimulate appetite and promote food-seeking behavior, leading to a persistent state of hunger and increased caloric intake. This amplification often results from hormonal dysregulation, such as elevated ghrelin levels or reduced sensitivity to satiety hormones, contributing significantly to weight gain and the development of obesity. It represents a clinical imbalance favoring energy intake over energy expenditure.
Origin
The term is a compound derived from the Greek orexis (appetite or desire) and genes (producing), meaning “appetite-producing.” “Amplification” denotes a pathological increase in the signal’s magnitude or effect. This concept is central to the neuroendocrinology of feeding behavior, specifically pointing to dysregulation in the hypothalamic feeding centers.
Mechanism
This phenomenon often involves a sustained increase in the secretion of the peptide hormone ghrelin from the stomach, which acts on the hypothalamus to stimulate the Agouti-related peptide (AgRP) and Neuropeptide Y (NPY) neurons, powerfully driving hunger. Concurrently, a state of leptin resistance can diminish the opposing satiety signal, leading to a net effect of amplified orexigenic drive. This chronic stimulation overcomes normal behavioral control, promoting hyperphagia.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.